NASDAQ:AVAV

AeroVironment (NASDAQ: AVAV) Stock Analysis: Wedbush Initiates Outperform Rating Amid Strong Q4 Performance

Font: Financial Modeling Prep  • Jun 30, 2026

Market Chart
  • Wedbush initiates an "Outperform" rating for AeroVironment, signaling confidence in the defense company's future performance.
  • The analyst firm sets a price target of $250.00, suggesting a significant 51.45% potential upside from the stock's current price.
  • Strong fourth-quarter results include revenue of $641.6 million (a 133% increase), adjusted EPS of $1.84, and a record $2.7 billion backlog.

AeroVironment (NASDAQ: AVAV) is a defense company that designs and manufactures unmanned aircraft systems, commonly known as drones. Its products are used for surveillance and other military applications. The company operates in a growing sector alongside competitors like Ondas Holdings Inc. (NASDAQ: ONDS), Kratos Defense and Security Solutions Inc. (NASDAQ: KTOS), and Red Cat Holdings Inc. (NASDAQ: RCAT).

Analyst firm Wedbush has initiated coverage on AeroVironment with an "Outperform" rating. This rating suggests the analyst believes the stock will perform better than the average return of the stocks they cover. The firm set a price target of $250.00 for the company's shares.

At the time of the announcement, AeroVironment's stock price was $165.07. The analyst's price target suggests a potential upside, or increase, of 51.45% from that price. This positive outlook follows a period where the stock saw a major sell-off, declining about 65% from its peak before finding support, as highlighted by Wall Street analysts.

The optimism is supported by a strong fourth-quarter performance. The company announced revenue of $641.6 million, a 133% increase from the prior year. This figure significantly beat Wall Street's expectation of $558 million. Adjusted earnings per share came in at $1.84, also surpassing the consensus estimate of $1.47.

Further strengthening the outlook, AeroVironment reported a record backlog with total annual bookings reaching $2.7 billion. A backlog represents confirmed orders that will provide future revenue. This, combined with tailwinds from Pentagon spending, points to a solid year ahead, as highlighted by Proactive Investors.

Market Overview
LIMN
Liminatus Pharma, Inc. Class A Common Stock
$0.15
29.00%
BITO
ProShares Bitcoin ETF
$8.72
-0.94%
AAL
American Airlines Group Inc.
$15.60
-0.19%
NU
Nu Holdings Ltd.
$13.79
-0.65%
ATAI
Atai Beckley Inc.
$7.15
33.40%
EOSER
Eos Energy Enterprises Inc. Rt
$0.03
-3.08%
OPEN
Opendoor Technologies Inc.
$4.57
-3.79%
NOK
Nokia Oyj
$10.38
-7.78%
TGHL
Growhub Ltd
$1.52
86.62%
IQST
iQSTEL Inc.
$1.22
38.45%